Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$0.52 - $5.92
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Last Price
Market Cap | $291.56M |
EV | $359.82M |
Shares Outstanding | 67.36M |
Beta | 1.98 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $6.83 |
P/E 2025E | - |
P/Revenue 2025E | 1.96x |
Revenue | 10.40% |
EPS | 7.00% |
Operating Cash Flow | -3.50% |
Free Cash Flow | 1.90% |
Revenue | 35.00% |
EPS | 56.70% |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | 55.17% |
Net Profit Margin 2025E | -12.96% |
ROE 2025E | - |
ROCE 2024 | -141.23% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Neuronetics, Inc.
STIM
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Sullivan, Keith
Employees
716
Website
neurostar.comIPO Date
2018-06-28
Headquarters
3222 Phoenixville Pike, Malvern, Pennsylvania, 19355, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved